Targeting AKT with oridonin inhibits growth of esophageal squamous cell carcinoma in vitro and patient-derived xenografts in vivo

被引：1
|
作者：
Song, Mengqiu [1 ]
Zhao, Ran [1 ]
Xie, Hua [2 ]
Chen, Hanyong [3 ]
Liu, Kangdong [4 ]
Bode, Ann M. [3 ]
Lee, Mee-Hyun [4 ]
Dong, Zigang [3 ,4 ]
机构：
[1] Zhengzhou Univ, China US Hormel Canc Inst, Sch Basic Med Sci, Dept Pathophysiol, Zhengzhou, Henan, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai, Peoples R China
[3] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA
[4] Zhengzhou Univ, China US Hormel Canc Inst, Collaborat Innovat Ctr Henan Prov Canc Chemopreve, Dept Pathophysiol,Sch Basic Med Sci, Zhengzhou, Henan, Peoples R China
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-4299
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4299
引用
收藏
页数：2
相关论文
共 50 条
  • [41] MSP58 Knockdown Inhibits the Proliferation of Esophageal Squamous Cell Carcinoma in Vitro and in Vivo
    Xu, Chun-Sheng
    Zheng, Jian-Yong
    Zhang, Hai-Long
    Zhao, Hua-Dong
    Zhang, Jing
    Wu, Guo-Qiang
    Wu, Lin
    Wang, Qing
    Wang, Wei-Zhong
    Zhang, Jian
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (07) : 3233 - 3238
  • [42] Ets2 knockdown inhibits tumorigenesis in esophageal squamous cell carcinoma in vivo and in vitro
    Li, Qinghua
    Yang, Lu
    Han, Kang
    Zhu, Liqiang
    Zhang, Yanting
    Ma, Shanshan
    Zhang, Kun
    Yang, Bo
    Guan, Fangxia
    ONCOTARGET, 2016, 7 (38) : 61458 - 61468
  • [43] Generation of patient-derived primary cell cultures and in-vivo models of penile squamous cell carcinoma
    Linxweiler, J.
    Ayoubian, H.
    Lohse, S.
    Stoeckle, M.
    Junker, K.
    EUROPEAN UROLOGY, 2023, 83 : S896 - S896
  • [44] Using Patient-Derived Xenografts to Explore the Efficacy of Treating Head-and-Neck Squamous Cell Carcinoma With Anlotinib
    Hu, Fangling
    Guo, Liang
    Yu, Jieqing
    Dai, Daofeng
    Xiong, Yuanping
    He, Yuanqiao
    Zhou, Wensheng
    PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
  • [45] Metformin Inhibited Growth, Invasion and Metastasis of Esophageal Squamous Cell Carcinoma in Vitro and in Vivo
    Liang, Feng
    Wang, Yu-Gang
    Wang, Changcheng
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 51 (03) : 1276 - 1286
  • [46] Corynoline inhibits esophageal squamous cell carcinoma growth via targeting Pim-3
    Shi, Yunshu
    Yuan, Qiang
    Chen, Yingying
    Li, Xiaoyu
    Zhou, Yujuan
    Zhou, Hao
    Peng, Feng
    Jiang, Yanan
    Qiao, Yan
    Zhao, Jimin
    Zhang, Chi
    Wang, Junyong
    Liu, Kangdong
    Dong, Zigang
    PHYTOMEDICINE, 2024, 123
  • [47] Novel celastrol derivatives inhibit the growth of hepatocellular carcinoma patient-derived xenografts
    Wei, Wei
    Wu, Song
    Wang, Xiaolin
    Sun, Chris Kin-Wai
    Yang, Xiaoyang
    Yan, Xinrui
    Chua, Mei-Sze
    So, Samuel
    ONCOTARGET, 2014, 5 (14) : 5819 - 5831
  • [48] Identification of new therapeutic targets in penile squamous cell carcinoma using patient-derived in-vitro and in-vivo models
    Linxweiler, J.
    Ayoubian, H.
    Mink, J.
    Pongratanakul, P.
    Skowron, M. A.
    Kotthoff, M.
    Stoeckle, M.
    Nettersheim, D.
    Junker, K.
    EUROPEAN UROLOGY, 2024, 85 : S1417 - S1417
  • [49] Telmisartan Inhibits Cell Proliferation and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inducing S-Phase Arrest In Vitro and In Vivo
    Matsui, Takanori
    Chiyo, Taiga
    Kobara, Hideki
    Fujihara, Shintaro
    Fujita, Koji
    Namima, Daisuke
    Nakahara, Mai
    Kobayashi, Nobuya
    Nishiyama, Noriko
    Yachida, Tatsuo
    Morishita, Asahiro
    Iwama, Hisakazu
    Masaki, Tsutomu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (13)
  • [50] Stromal-targeting with quercetin in patient-derived models of head and neck squamous cell carcinoma (HNSCC)
    Li, Hui
    Piao, Wenying
    Lau, Pik Yuk
    Lau, Chin Wang
    Chan, Jason Ying Kuen
    Su, Yu Xiong
    Huang, Leaf
    Hu, Kai Li
    Lui, Vivian Wai Yan
    CANCER RESEARCH, 2019, 79 (13)
12345